Pay in 4 interest-free payments of $6.50 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
We help patients across St George , Cedar City , and Salt Lake City Utah achieve healthy, sustainable weight control through physician-supervised GLP-1 and GIP programs that emphasize evidence, safety, and lasting results
Many people notice reduced appetite and fewer food cravings within the first one to four weeks
If patients experience persistent difficulty with injections, inconsistent medication effects, or injection site reactions, they should contact their healthcare provider for additional guidance
Methods Trial details EMBRAZE was a randomized, double-blind, placebo-controlled, phase 2 trial (NCT06445075) conducted at seven sites in the United States to evaluate the efficacy, safety, pharmacokinetics and pharmacodynamics of apitegromab in adults receiving tirzepatide
US$ 26.47
US$ 27.77
US$ 27.20
US$ 26.52
US$ 27.12
US$ 22.41
US$ 29.28
US$ 21.66
US$ 25.85
